BioMarker Strategies

Bio Marker Strategies

Biotechnology, Crabbs Br Way, Rockville, , 20855, Maryland, 15601, United States, 11-50 Employees

biomarkerstrategies.com

  • facebook
  • LinkedIn

phone no Phone Number: 41********

Who is BIOMARKER STRATEGIES

BioMarker Strategies has developed the proprietary SnapPath Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with sol...

Read More

map

industries-icon Industry: Biotechnology

SIC SIC Code: 8069 | NAICS Code: 541720 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from BIOMARKER STRATEGIES

BioMarker Strategies Org Chart and Mapping

Employees

Amy James

Business Office Manager

Denise Thurber

Research Laboratory Technician

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding BioMarker Strategies

Answer: BioMarker Strategies's headquarters are located at Crabbs Br Way, Rockville, , 20855, Maryland, 15601, United States

Answer: BioMarker Strategies's phone number is 41********

Answer: BioMarker Strategies's official website is https://biomarkerstrategies.com

Answer: BioMarker Strategies's revenue is $5 Million to $10 Million

Answer: BioMarker Strategies's SIC: 8069

Answer: BioMarker Strategies's NAICS: 541720

Answer: BioMarker Strategies has 11-50 employees

Answer: BioMarker Strategies is in Biotechnology

Answer: BioMarker Strategies contact info: Phone number: 41******** Website: https://biomarkerstrategies.com

Answer: BioMarker Strategies has developed the proprietary SnapPath Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. SnapPath is unique in automating and standardizing functional ex vivo profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. Our PathMAP Functional Signaling Profiles, created using the SnapPath system, represent a new class of biomarker tests that are highly predictive of individual response to targeted treatments for solid tumors, because they are based on information available only from live cells. Our business development efforts are directed toward entering into funded collaborations with companies developing targeted therapies for patients with solid tumors. The capabilities of SnapPath and the Functional Profiles it enables are available for Research Use in preclinical studies in tumorgraft and other model systems, and in early clinical studies to assess pharmacodynamic changes in the solid tumors of individual patients.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access